Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome (2009)
Source: International Journal of Clinical Practice. Unidade: FMRP
Subjects: SÍNDROME DO OVÁRIO POLICÍSTICO, DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS
ABNT
SOARES, G. M. et al. Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome. International Journal of Clinical Practice, v. 63, n. 1, p. 160-169, 2009Tradução . . Disponível em: https://doi.org/10.1111/j.1742-1241.2008.01877.x. Acesso em: 06 set. 2024.APA
Soares, G. M., Vieira, C. S., Martins, W. P., Reis, R. M. dos, Sá, M. F. S. de, & Ferriani, R. A. (2009). Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome. International Journal of Clinical Practice, 63( 1), 160-169. doi:10.1111/j.1742-1241.2008.01877.xNLM
Soares GM, Vieira CS, Martins WP, Reis RM dos, Sá MFS de, Ferriani RA. Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome [Internet]. International Journal of Clinical Practice. 2009 ; 63( 1): 160-169.[citado 2024 set. 06 ] Available from: https://doi.org/10.1111/j.1742-1241.2008.01877.xVancouver
Soares GM, Vieira CS, Martins WP, Reis RM dos, Sá MFS de, Ferriani RA. Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome [Internet]. International Journal of Clinical Practice. 2009 ; 63( 1): 160-169.[citado 2024 set. 06 ] Available from: https://doi.org/10.1111/j.1742-1241.2008.01877.x